| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1abc4031629be22aec464654c1831e66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d55b7fecdb4a012bffcd876954ae7d40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0beeb52f32267c5b6b94bb5de0b30499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0aae33d98e2d787958f0e63e76212a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c77af3349b7ce9dfd6b09b1c4ef1134e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6bab44805d77f87708e108061e2d77d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33dde8053f260c48448caf6e9728490c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c4bf17f621d98a39ee73b935937d379
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7258670200fe95d29091a4cb6da937d6 |
| publicationDate |
2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013143954-A1 |
| titleOfInvention |
Recombinant vector for suppressing proliferation of human papilloma virus cells including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papilloma virus |
| abstract |
The present invention relates to a cervical cancer therapeutic agent comprising a recombinant vector containing a gene that encodes adenylate cyclase activating polypeptide 1 (pituitary) (ADCYAP1). The use of the recombinant vector and a pharmaceutical composition comprising the recombinant vector can prevent or treat cervical cancer by inhibiting the proliferation of cervical cancer cells. |
| priorityDate |
2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |